Israel Englander Bicycle Therapeutics PLC Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.02 - $24.69 $750,890 - $926,047	37,507 New	37,507 $759,000
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $2.26 Million - $3.78 Million	170,376 Added 216.33%	249,135 $4.5 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $1.17 Million - $1.78 Million	61,923 Added 367.8%	78,759 $2.01 Million
Q1 2023 May 15, 2023	SELL	$20.02 - $31.37 $3.04 Million - $4.76 Million	-151,887 Reduced 90.02%	16,836 $358,000
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $523,040 - $844,773	25,677 Added 17.95%	168,723 $4.99 Million
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $3.33 Million - $5.42 Million	-190,655 Reduced 57.13%	143,046 $3.33 Million
Q2 2022 Aug 15, 2022	BUY	$12.95 - $46.99 $2.21 Million - $8 Million	170,334 Added 104.26%	333,701 $5.6 Million
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $426,676 - $632,782	10,635 Added 6.96%	163,367 $7.17 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $6.37 Million - $9.34 Million	152,732 New	152,732 $9.3 Million
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $569,145 - $900,859	-20,363 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$27.0 - $32.28 $549,801 - $657,317	20,363 New	20,363 $618,000
Q1 2021 May 17, 2021	SELL	$19.12 - $30.25 $276,131 - $436,870	-14,442 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.95 - $21.36 $17,249 - $20,526	961 Added 7.13%	14,442 $259,000
Q3 2020 Nov 16, 2020	SELL	$15.3 - $20.8 $73,944 - $100,526	-4,833 Reduced 26.39%	13,481 $257,000
Q2 2020 Aug 14, 2020	BUY	$12.63 - $18.21 $38,811 - $55,959	3,073 Added 20.16%	18,314 $284,000
Q1 2020 May 14, 2020	SELL	$9.82 - $18.0 $58,419 - $107,082	-5,949 Reduced 28.07%	15,241 $228,000
Q4 2019 Feb 14, 2020	SELL	$7.68 - $11.08 $104,286 - $150,455	-13,579 Reduced 39.05%	21,190 $200,000
Q3 2019 Nov 14, 2019	SELL	$6.74 - $12.01 $125,303 - $223,277	-18,591 Reduced 34.84%	34,769 $396,000
Q2 2019 Aug 15, 2019	SELL	$10.06 - $14.63 $948,004 - $1.38 Million	-94,235 Reduced 63.85%	53,360 $537,000
Q2 2019 Aug 14, 2019	BUY	$10.06 - $14.63 $1.48 Million - $2.16 Million	147,595 New	147,595 $4.38 Million

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

Baker Bros. Advisors LP New York, NY

9.4M
Shares

$138 Million
2.28% of portfolio
Deep Track Capital, LP Greenwich, CT

3.55M
Shares

$52.1 Million
2.97% of portfolio
Fcpm Iii Services B.V. Naarden, P7

2.34M
Shares

$34.4 Million
9.09% of portfolio
Ra Capital Management, L.P. Boston, MA

2.25M
Shares

$33.1 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

1.96M
Shares

$28.7 Million
0.74% of portfolio

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account